This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Pharmacyclics Inc
PCYC : NASDAQ : Health Care
$133.34 2.31 | 1.76%
Today's Range: 130.32 - 133.71
Avg. Daily Volume: 720,100
12/18/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
PCYC PHARMACYCLICS INC 134.99 10197.01 123.84 563.09 305.85
MDVN MEDIVATION INC 108.02 8385.05 76.61 532.37 149.36
ALNY ALNYLAM PHARMACEUTICALS INC 100.22 7710.02 n/m 37.39 -16.58
CBST CUBIST PHARMACEUTICALS INC 96.27 7357.15 118.85 1164.53 16.38
ISIS ISIS PHARMACEUTICALS INC 61.87 7309.38 n/m 171.55 37.33
UTHR UNITED THERAPEUTICS CORP 131.23 6234.61 38.60 1231.17 14.87
ALXN ALEXION PHARMACEUTICALS INC 191.62 37995.75 79.84 2076.17 45.19
VRTX VERTEX PHARMACEUTICALS INC 120.78 29050.25 n/m 787.02 -34.14
BMRN BIOMARIN PHARMACEUTICAL INC 92.90 13699.59 n/m 667.06 25.02
INCY INCYTE CORP 75.92 12826.08 n/m 484.59 30.36
GRFS GRIFOLS SA 32.74 12478.28 20.99 4086.63 10.24
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PCYC Ind Avg S&P 500
123.84 66.62 19.74
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs